LLY

930.6

-5.49%↓

JNJ

238.04

-1.99%↓

ABBV

219.84

-0.68%↓

NVS

154.48

+0.12%↑

AZN

191.24

-0.38%↓

LLY

930.6

-5.49%↓

JNJ

238.04

-1.99%↓

ABBV

219.84

-0.68%↓

NVS

154.48

+0.12%↑

AZN

191.24

-0.38%↓

LLY

930.6

-5.49%↓

JNJ

238.04

-1.99%↓

ABBV

219.84

-0.68%↓

NVS

154.48

+0.12%↑

AZN

191.24

-0.38%↓

LLY

930.6

-5.49%↓

JNJ

238.04

-1.99%↓

ABBV

219.84

-0.68%↓

NVS

154.48

+0.12%↑

AZN

191.24

-0.38%↓

LLY

930.6

-5.49%↓

JNJ

238.04

-1.99%↓

ABBV

219.84

-0.68%↓

NVS

154.48

+0.12%↑

AZN

191.24

-0.38%↓

Search

Nektar Therapeutics

Gesloten

74.92 4.43

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

71.85

Max

75.63

Belangrijke statistieken

By Trading Economics

Inkomsten

-557K

-36M

Verkoop

10M

22M

EPS

-1.29

Winstmarge

-165.447

Werknemers

61

EBITDA

10M

-19M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+76.42% upside

Dividenden

By Dow Jones

Volgende Winsten

7 mei 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

86M

2B

Vorige openingsprijs

70.49

Vorige sluitingsprijs

74.92

Technische score

By Trading Central

Vertrouwen

Strong Bearish Evidence

Nektar Therapeutics Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

17 mrt 2026, 22:42 UTC

Winsten

Prudential PLC 2025 Adjusted Operating Profit Rises

17 mrt 2026, 21:40 UTC

Winsten

Alimentation Couche-Tard Records Higher Profit, Revenue in 3Q

17 mrt 2026, 23:56 UTC

Marktinformatie

BHP's Next CEO Likely to Build On Existing Strategic Direction -- Market Talk

17 mrt 2026, 23:46 UTC

Marktinformatie

Nikkei May Rise After Recent Selloffs -- Market Talk

17 mrt 2026, 23:42 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

17 mrt 2026, 23:42 UTC

Marktinformatie

RBA's Return to Policy Tightening Will Work -- Market Talk

17 mrt 2026, 23:38 UTC

Marktinformatie

Gold Edges Lower on Possible Position Adjustments Before FOMC Decision -- Market Talk

17 mrt 2026, 23:24 UTC

Marktinformatie

Global Energy Roundup: Market Talk

17 mrt 2026, 23:24 UTC

Marktinformatie

New Woodside CEO Seen as Low-Risk Appointment -- Market Talk

17 mrt 2026, 22:22 UTC

Marktinformatie

BHP Hands Reins to Growth-Focused Executive -- Market Talk

17 mrt 2026, 22:20 UTC

Winsten

Prudential PLC 2025 New Business Profit $2.78B Vs. $2.46B >2378.HK

17 mrt 2026, 22:20 UTC

Winsten

Prudential PLC 2025 Adj Operating Profit $3.31B Vs. $3.13B >2378.HK

17 mrt 2026, 22:07 UTC

Winsten

Nvidia Says It Is Restarting Production of AI Chips for Sale in China -- WSJ

17 mrt 2026, 22:05 UTC

Winsten

ZTO Express (Cayman): Frank Zhen Wei to Resign From Board

17 mrt 2026, 22:04 UTC

Winsten

ZTO Express (Cayman): Board Approves Repurchase of Up to $1.5B of Shares Over Next 24 Months >ZTO

17 mrt 2026, 22:03 UTC

Winsten

ZTO Express (Cayman) Raises Semiannual Dividend to 39c Vs. 30c >ZTO

17 mrt 2026, 22:01 UTC

Winsten

ZTO Express (Cayman) 4Q Adj EPS 47c >ZTO

17 mrt 2026, 22:01 UTC

Winsten

ZTO Express (Cayman) 4Q Rev $2.08B >ZTO

17 mrt 2026, 22:01 UTC

Winsten

ZTO Express (Cayman) 4Q EPS 47c >ZTO

17 mrt 2026, 21:26 UTC

Winsten

Oklo Stock Wavers After Earnings, but the Nuclear Start-Up Has Good News -- Barrons.com

17 mrt 2026, 21:09 UTC

Winsten

Couche-Tard: 12 Company-Operated Stores Acquired During 3Q

17 mrt 2026, 21:08 UTC

Winsten

Couche-Tard 3Q Consolidated Same-Store Merchandise Revenue Up 2% >ATD.T

17 mrt 2026, 21:08 UTC

Winsten

Couche-Tard 3Q Adj EPS 81c >ATD.T

17 mrt 2026, 21:07 UTC

Winsten

Couche-Tard 3Q EPS 82c >ATD.T

17 mrt 2026, 21:06 UTC

Winsten

Couche-Tard 3Q Rev $21.8B >ATD.T

17 mrt 2026, 21:05 UTC

Winsten

Couche-Tard 3Q Adj EPS 81c >ATD.T

17 mrt 2026, 21:05 UTC

Winsten

Couche-Tard 3Q Rev $21.8B >ATD.T

17 mrt 2026, 21:05 UTC

Winsten

Couche-Tard 3Q EPS 82c >ATD.T

17 mrt 2026, 21:05 UTC

Winsten

Couche-Tard 3Q Net $757.2M >ATD.T

17 mrt 2026, 20:50 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Energy & Utilities Roundup: Market Talk

Peer Vergelijking

Prijswijziging

Nektar Therapeutics Prognose

Koersdoel

By TipRanks

76.42% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 127.39 USD  76.42%

Hoogste 165 USD

Laagste 70.36 USD

Gebaseerd op 7 Wall Street-analisten die 12-maands prijsdoelen bieden voor Nektar Therapeutics - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

7 ratings

7

Buy

0

Hold

0

Sell

Technische score

By Trading Central

0.5949 / 0.7406Steun & Weerstand

Korte Termijn

Strong Bearish Evidence

Gemiddeld Termijn

Strong Bearish Evidence

Lange Termijn

Bearish Evidence

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

help-icon Live chat